West Pharmaceutical Services (FRA:WPS) Additional Paid-In Capital : €51 Mil(As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is West Pharmaceutical Services Additional Paid-In Capital?

West Pharmaceutical Services's quarterly additional paid-in capital declined from Sep. 2023 (€115 Mil) to Dec. 2023 (€110 Mil) but then stayed the same from Dec. 2023 (€110 Mil) to Mar. 2024 (€51 Mil).

West Pharmaceutical Services's annual additional paid-in capital declined from Dec. 2021 (€220 Mil) to Dec. 2022 (€219 Mil) and declined from Dec. 2022 (€219 Mil) to Dec. 2023 (€110 Mil).

West Pharmaceutical Services Additional Paid-In Capital Historical Data

The historical data trend for West Pharmaceutical Services's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Additional Paid-In Capital Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

245.43

219.72

220.37

219.20

110.22

West Pharmaceutical Services Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															169.43	146.02	114.88	110.22	50.78

West Pharmaceutical Services Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

West Pharmaceutical Services Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services (FRA:WPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (FRA:WPS) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-0645

Website

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.